Skip to content
Home
Portfolio
People
Sustainability
News
Home
Portfolio
People
Sustainability
News
NEWS
NEWS
NEWS
NEWS
NEWS
NEWS
NEWS
NEWS
NEWS
NEWS
NEWS
NEWS
The latest news on
XGEN
and its companies.
Linkedin
Follow us on LinkedIn
Portfolio Company News
XGEN News
All Categories
Portfolio Company News - Press Release
Clinical trial published in Nature Medicine shows proof of concept of PAGE’s therapeutic approach
January 24, 2025
PAGE THERAPEUTICS
PAGE Therapeutics, a biotech company focused on tackling metastatic cancer spread at its root, is pleased to announce the publication...
Portfolio Company News - Press Release
Tes Pharma Announces Formation of AKI Clinical Advisory Board
January 23, 2025
TES PHARMA
Tes Pharma, a biotech company focused on delivering first-in-class therapeutics for high unmet medical needs in oncology, renal and metabolic...
Portfolio Company News - Press Release
Tes Pharma Announces Renewal of Research and Development Collaboration with Intercept Pharmaceuticals
January 14, 2025
TES PHARMA
Tes Pharma, a biotech company focused on delivering first-in-class therapeutics for high unmet medical needs in oncology, renal and metabolic...
Press Release - XGEN News
XGEN Venture Announces Final Closing of €180M ($190M) Life Sciences Fund
December 19, 2024
Business Wire
XGEN Venture, a leading venture capital firm specializing in life sciences investments, proudly announces the final closing of its XGEN...
Portfolio Company News - Press Release
Tes Pharma Announces Extension of its Series A Financing with Indaco Venture Partners
December 19, 2024
TES PHARMA
Tes Pharma, a biotech company focused on delivering first-in-class therapeutics for high unmet medical needs in oncology, renal and metabolic...
Portfolio Company News - Press Release
iOnctura reaches new clinical milestones in uveal melanoma
December 11, 2024
iOnctura
PAGE Therapeutics is a Swiss preclinical-stage biotechnology company spun out of ETH Zurich, based on the groundbreaking science of Prof....
Portfolio Company News - Press Release
Genespire raises €46.6 million (~$52 million) in a Series B round to advance its first pediatric in-vivo gene therapy into the clinic
September 25, 2024
Genespire
Genespire, a biotechnology company developing off-the-shelf gene therapies for pediatric patients affected by genetic diseases, today announced the closing of...
Portfolio Company News - Press Release
Protembis receives €20 million backing from the European Investment Bank
July 30, 2024
Protembis
New financing for Protembis to accelerate ‘research and development’ programs, global ‘market access’ initiatives, and to complete the pivotal FDA...
Press Release - XGEN News
XGEN Venture Announces €160 million First Life Science Fund
May 23, 2024
Business Wire
XGEN Venture – a newly formed Venture Capital firm - announces its first fund, XGEN Venture Life Science Fund, with...